Biotech Small Cap Momentum Eases
Biotech Momentum Eased Slightly Last Week Many of our SMID BIOTECH Stock Picks are Doing Very Well: ADPT, CRMD, CRSP, EYPT, GH, NTRA, RNA, RZLT,TEM, SUPN, Best performers are in Precision Oncology and Next -GEN Diagnostics enabled by AI and genomics and Neurodegenerative Diseases.. We sold...
Healthcare Sector is Still Lagging- Can you Beat the S&P 500 with more Biotech?…. Update-1. biotechs!
Update-1 SMID biotechs rally underway as all there of our tracking ETFs are up ARKG up 5.6% , IBB, up 1.57%, XBI up 1.345 as a broad based rally pullls many stocks to new highs. Interest rate cut is "baked in". New small cap picks are all up: CBIO, PSNL, XNCR. Personalis (PSNL) big mover: new...
Small Cap Biopharmaceutical Stocks: Interim Update-3 Focus stocks: CBIO, PSNL, XNCR.
Small Cap Biopharma Stocks: Momentum Looks Good for Gains Our bellwether ETFs for this group are: Ark Genomic Revolution (ARKG) up 3% 1m and 5% YTD; S&P SPDR Biotech( XBI) up 7.66% 1m and 3.79% YTD. Most of these picks have been screened for analyst ratings (buy or above) and adequate cash...
Large Cap Biopharmaceuticals had a Good Month
Large Cap Biopharma Stocks Did Well in August Biopharma stocks offer growth plus dividends.Standouts are ABBV, AZN and GILD. Comeback candidates for 2026: from LLY,REGN and VRTX. Risk remains from tariffs and pushback from Trump Administration policies on drug pricing. Innovation is still key...
Focus on Small Cap Biotechs Now For A Q4 Rally…Update-1
8/28/25 UPDATE-1 A small cap rally has helped SMID biotechs stabilize to some degree with the IWM up 5.4% over one month and 7.04% YTD but the anticipated big rally in general small caps has not yet developed.For example the ARKG is seriously lagging down over 3% MTD but up 4.43% YTD mainly...